Changes in Monkey Plasma Purines Induced by Repeated Doses of CI-1000, a Novel Inhibitor of Purine Nucleoside Phosphorylase (Q42277693)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Changes in monkey plasma purines induced by repeated doses of CI-1000, a novel inhibitor of purine nucleoside phosphorylase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Changes in Monkey Plasma Purines Induced by Repeated Doses of CI-1000, a Novel Inhibitor of Purine Nucleoside Phosphorylase (English)

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

27 July 2024

author name string

D. G. Robertson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7660884

27 July 2024

E. R. Urda

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7660884

27 July 2024

M. R. Bleavins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7660884

27 July 2024

N. D. Lalwani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7660884

27 July 2024

language of work or name

English

0 references

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://link.springer.com/content/pdf/10.1007/978-1-4615-2584-4_38

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Advances in Experimental Medicine and Biology

27 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

173-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

Comparison of high-performance liquid chromatographic serum profiles of humans and dogs

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. II. Effects on nucleoside catabolism in human and rat blood in vitro

27 July 2024

3

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity

27 July 2024

6

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

27 July 2024

7

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972

27 July 2024

8

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955

27 July 2024

11

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Pharmacokinetics/Pharmacodynamics of CI-1000, a Purine Nucleoside Phosphorylase (PNP) Inhibitor, in Rats and Monkeys

27 July 2024

13

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency

27 July 2024

15

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973

27 July 2024

17

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

A new case of purine nucleoside phosphorylase deficiency: enzymologic, clinical, and immunologic characteristics

27 July 2024

18

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes

27 July 2024

21

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

Purine Nucleoside Phosphorylase Deficiency Associated with Selective Cellular Immunodeficiency

27 July 2024

22

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR).

27 July 2024

23

1 reference

https://api.crossref.org/works/10.1007/978-1-4615-2584-4_38

27 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7660884%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference